OraSure Technologies (OSUR) Debt/Assets Ratio: History & Chart

OraSure Technologies, Inc.(OSUR)

Medical - Instruments & Supplies · Bethlehem, PA

$3.77-0.34 (-8.27%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About OraSure Technologies, Inc.

OraSure Technologies, Inc. and its affiliates are a global leader in the development, production, and commercialization of advanced oral fluid diagnostic solutions and specialized specimen collection tools, serving markets across the United States, Europe, and other international regions. The company operates through two primary divisions: Diagnostics and Molecular Solutions. Its diverse Diagnostics portfolio features a range of crucial offerings, such as the InteliSwab rapid tests for COVID-19 (including professional and prescription versions). It also provides several OraQuick rapid tests, encompassing solutions for HIV (Rapid, In-Home, and Self-Test versions), Hepatitis C (HCV rapid antibody), and Ebola (rapid antigen). Further diagnostic tools include the OraSure oral fluid collection device, utilized for HIV-1 antibody screening and confirmation; the Intercept drug testing systems; various immunoassay tests and reagents; and the Q.E.D. saliva alcohol test. Within its Molecular Solutions segment, OraSure offers an array of genomic products, notably under the Oragene and ORAcollect brand names, alongside specialized microbiome collection solutions and comprehensive GenoFIND genomics laboratory services. The company also supplies collection devices like ORAcollect, RNA, OMNIgene, and RAL, specifically designed for COVID-19 molecular testing. Another key offering is the Colli-Pee device, engineered for the precise volumetric collection of first-void urine. Furthermore, OraSure produces and distributes advanced kits for the collection, stabilization, transportation, and storage of genetic material samples, critical for molecular testing in diverse fields such as academic research, commercial applications (including ancestry, disease risk management, lifestyle analysis), and animal testing. Complementing these, it also provides various other diagnostic tools, including immunoassays and in vitro diagnostic tests. OraSure's sophisticated products and services are distributed to a wide array of clients, including clinical laboratories, hospitals, clinics, various community and public health organizations, wholesale distributors, governmental bodies, medical practices, and a broad spectrum of commercial and industrial entities. Established in 2000, OraSure Technologies, Inc. maintains its corporate headquarters in Bethlehem, Pennsylvania.

Bethlehem, PA

500 employees

www.orasure.com

Healthcare / Medical - Instruments & Supplies

Sector: Healthcare
Industry: Medical - Instruments & Supplies
CEO: Carrie Eglinton Manner

View full financials

OSUR Debt to Assets Ratio Metrics

DEBT TO ASSETS RATIO

3.35%

DEBT TO ASSETS RATIO AVG TTM

4.73%

DEBT TO ASSETS RATIO AVG 3Y

3.04%

DEBT TO ASSETS RATIO AVG 5Y

3.01%

DEBT TO ASSETS RATIO AVG 10Y

1.95%

DEBT TO ASSETS RATIO AVG 15Y

1.79%

DEBT TO ASSETS RATIO AVG 20Y

3.06%

CURRENT VS TTM AVG

-29.10%

CURRENT VS 3Y AVG

+10.32%

CURRENT VS 5Y AVG

+11.50%

CURRENT VS 10Y AVG

+72.22%

CURRENT VS 15Y AVG

+87.63%

CURRENT VS 20Y AVG

+9.60%

SECTOR MEDIAN · HEALTHCARE

0.09%

median of 874 covered companies

CURRENT VS SECTOR MEDIAN

+3627.00%

vs the sector median at left

NAME	MARKET CAP	DEBT TO ASSETS RATIO	TTM	3Y	5Y
OraSure Technologies, Inc. (OSUR)	$259.56M	3.35%	4.73%	3.04%	3.01%
Treace Medical Concepts, Inc. (TMCI)vs ›	$259.49M	0.40%	N/A	N/A	N/A
Eupraxia Pharmaceuticals Inc. (EPRX)vs ›	$259.14M	0.01%	N/A	N/A	N/A
Lexeo Therapeutics, Inc. Common Stock (LXEO)vs ›	$259.12M	0.03%	N/A	N/A	N/A
Palisade Bio, Inc. (PALI)vs ›	$258.63M	0.00%	N/A	N/A	N/A
X4 Pharmaceuticals, Inc. (XFOR)vs ›	$261.27M	0.31%	N/A	N/A	N/A
Inhibikase Therapeutics, Inc. (IKT)vs ›	$261.43M	0.00%	N/A	N/A	N/A
AC Immune S.A. (ACIU)vs ›	$256.47M	0.03%	N/A	N/A	N/A
TriSalus Life Sciences, Inc. (TLSI)vs ›	$262.92M	0.55%	N/A	N/A	N/A
Anika Therapeutics, Inc. (ANIK)vs ›	$255.88M	0.13%	N/A	N/A	N/A

NAME

MARKET CAP

DEBT TO ASSETS RATIO

TTM

OraSure Technologies, Inc. (OSUR)

$259.56M

3.35%

4.73%

3.04%

3.01%

Treace Medical Concepts, Inc. (TMCI)vs ›

$259.49M

0.40%

N/A

Eupraxia Pharmaceuticals Inc. (EPRX)vs ›

$259.14M

0.01%

N/A

Lexeo Therapeutics, Inc. Common Stock (LXEO)vs ›

$259.12M

0.03%

N/A

Palisade Bio, Inc. (PALI)vs ›

$258.63M

0.00%

N/A

X4 Pharmaceuticals, Inc. (XFOR)vs ›

$261.27M

0.31%

N/A

Inhibikase Therapeutics, Inc. (IKT)vs ›

$261.43M

0.00%

N/A

AC Immune S.A. (ACIU)vs ›

$256.47M

0.03%

N/A

TriSalus Life Sciences, Inc. (TLSI)vs ›

$262.92M

0.55%

N/A

Anika Therapeutics, Inc. (ANIK)vs ›

$255.88M

0.13%

N/A

Debt to Assets Ratio FAQ

What is the debt to assets ratio for OraSure Technologies, Inc. (OSUR)?

The debt to assets ratio for OSUR stock is 3.35%.

Is OraSure Technologies, Inc.'s debt to assets ratio high or low?

The debt to assets ratio of 3.35% is 12% above its 5-year average of 3.01%, near the low end of its 5-year range (2.39%–10.67%).

What is the TTM average debt to assets ratio for OraSure Technologies, Inc. (OSUR)?

The TTM average debt to assets ratio for OSUR stock is 4.73%.

What is the 3Y average debt to assets ratio for OraSure Technologies, Inc. (OSUR)?

The 3Y average debt to assets ratio for OSUR stock is 3.04%.

What is the 5Y average debt to assets ratio for OraSure Technologies, Inc. (OSUR)?

The 5Y average debt to assets ratio for OSUR stock is 3.01%.

What is the 10Y average debt to assets ratio for OraSure Technologies, Inc. (OSUR)?

The 10Y average debt to assets ratio for OSUR stock is 1.95%.

What is the 15Y average debt to assets ratio for OraSure Technologies, Inc. (OSUR)?

The 15Y average debt to assets ratio for OSUR stock is 1.79%.

What is the 20Y average debt to assets ratio for OraSure Technologies, Inc. (OSUR)?

The 20Y average debt to assets ratio for OSUR stock is 3.06%.

DATE	DEBT TO ASSETS RATIO
2026-06-30	3.35%
2026-03-31	10.67%
2025-12-31	3.27%
2025-09-30	3.18%
2025-06-30	3.17%
2025-03-31	3.10%
2024-12-31	3.04%
2024-09-30	2.39%
2024-06-30	2.71%
2024-03-31	2.78%
2023-12-31	2.80%
2023-09-30	3.28%
2023-06-30	3.40%
2023-03-31	2.63%
2022-12-31	2.82%
2022-09-30	4.31%
2022-06-30	4.58%
2022-03-31	3.55%
2021-12-31	2.66%
2021-09-30	3.22%
2021-06-30	2.78%
2021-03-31	1.38%
2020-12-31	1.35%
2020-09-30	1.49%
2020-06-30	1.64%
2020-03-31	2.08%
2019-12-31	2.07%
2019-09-30	1.50%
2019-06-30	1.65%
2019-03-31	1.72%
2018-12-31	0.00%
2018-09-30	0.00%
2018-06-30	0.00%
2018-03-31	0.00%
2017-12-31	0.00%
2017-09-30	0.00%
2017-06-30	0.00%
2017-03-31	0.00%
2016-12-31	0.00%
2016-09-30	0.00%
2016-06-30	0.00%
2016-03-31	0.00%
2015-12-31	0.00%
2015-09-30	0.00%
2015-06-30	0.00%
2015-03-31	0.00%
2014-12-31	0.00%
2014-09-30	0.00%
2014-06-30	0.00%
2014-03-31	0.00%
2013-12-31	0.00%
2013-09-30	0.00%
2013-06-30	0.00%
2013-03-31	0.00%
2012-12-31	0.00%
2012-09-30	0.00%
2012-06-30	5.65%
2012-03-31	5.75%
2011-12-31	5.70%
2011-09-30	6.04%
2011-06-30	6.22%
2011-03-31	6.43%
2010-12-31	6.36%
2010-09-30	6.52%
2010-06-30	6.49%
2010-03-31	6.74%
2009-12-31	6.54%
2009-09-30	6.61%
2009-06-30	7.03%
2009-03-31	6.88%
2008-12-31	6.72%
2008-09-30	5.66%
2008-06-30	5.56%
2008-03-31	5.65%
2007-12-31	5.60%
2007-09-30	6.12%
2007-06-30	6.62%
2007-03-31	6.79%
2006-12-31	6.80%
2006-09-30	7.31%
2006-06-30	7.56%
2006-03-31	0.81%
2005-12-31	1.03%
2005-09-30	1.61%
2005-06-30	2.04%
2005-03-31	2.44%
2004-12-31	2.79%
2004-09-30	3.16%
2004-06-30	3.44%
2004-03-31	3.87%
2003-12-31	4.16%
2003-09-30	9.92%
2003-06-30	11.35%
2003-03-31	11.96%
2002-12-31	12.52%
2002-09-30	13.44%

DATE

DEBT TO ASSETS RATIO

2026-06-30

3.35%

2026-03-31

10.67%

2025-12-31

3.27%

2025-09-30

3.18%

2025-06-30

3.17%

2025-03-31

3.10%

2024-12-31

3.04%

2024-09-30

2.39%

2024-06-30

2.71%

2024-03-31

2.78%

2023-12-31

2.80%

2023-09-30

3.28%

2023-06-30

3.40%

2023-03-31

2.63%

2022-12-31

2.82%

2022-09-30

4.31%

2022-06-30

4.58%

2022-03-31

3.55%

2021-12-31

2.66%

2021-09-30

3.22%

2021-06-30

2.78%

2021-03-31

1.38%

2020-12-31

1.35%

2020-09-30

1.49%

2020-06-30

1.64%

2020-03-31

2.08%

2019-12-31

2.07%

2019-09-30

1.50%

2019-06-30

1.65%

2019-03-31

1.72%

2018-12-31

0.00%

2018-09-30

0.00%

2018-06-30

0.00%

2018-03-31

0.00%

2017-12-31

0.00%

2017-09-30

0.00%

2017-06-30

0.00%

2017-03-31

0.00%

2016-12-31

0.00%

2016-09-30

0.00%

2016-06-30

0.00%

2016-03-31

0.00%

2015-12-31

0.00%

2015-09-30

0.00%

2015-06-30

0.00%

2015-03-31

0.00%

2014-12-31

0.00%

2014-09-30

0.00%

2014-06-30

0.00%

2014-03-31

0.00%

2013-12-31

0.00%

2013-09-30

0.00%

2013-06-30

0.00%

2013-03-31

0.00%

2012-12-31

0.00%

2012-09-30

0.00%

2012-06-30

5.65%

2012-03-31

5.75%

2011-12-31

5.70%

2011-09-30

6.04%

2011-06-30

6.22%

2011-03-31

6.43%

2010-12-31

6.36%

2010-09-30

6.52%

2010-06-30

6.49%

2010-03-31

6.74%

2009-12-31

6.54%

2009-09-30

6.61%

2009-06-30

7.03%

2009-03-31

6.88%

2008-12-31

6.72%

2008-09-30

5.66%

2008-06-30

5.56%

2008-03-31

5.65%

2007-12-31

5.60%

2007-09-30

6.12%

2007-06-30

6.62%

2007-03-31

6.79%

2006-12-31

6.80%

2006-09-30

7.31%

2006-06-30

7.56%

2006-03-31

0.81%

2005-12-31

1.03%

2005-09-30

1.61%

2005-06-30

2.04%

2005-03-31

2.44%

2004-12-31

2.79%

2004-09-30

3.16%

2004-06-30

3.44%

2004-03-31

3.87%

2003-12-31

4.16%

2003-09-30

9.92%

2003-06-30

11.35%

2003-03-31

11.96%

2002-12-31

12.52%

2002-09-30

13.44%

Debt to Assets Ratio: 3.35%

OSUR Debt to Assets Ratio

OSUR Average Debt to Assets Ratio Chart

OSUR Current vs Average Debt to Assets Ratio Chart

OSUR Debt to Assets Ratio Metrics

OSUR Competitors' Debt to Assets Ratio

Leverage Ratios Comparison

Debt to Assets Ratio Formula & Definition

Debt to Assets Ratio FAQ

OSUR Debt to Assets Ratio History

Related Metrics